Endometrial Priming for Embryo Transfer

• Status: Completed
• Trial end date: 2015-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this trial is compare two different endometrial priming protocols

• women that receive oral estrogens

• women that receive transdermal estrogens

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Parc de Salut Mar
• Treatments: Estrogens; Permixon; Saw palmetto extract

Criteria

Inclusion Criteria:

• Women between 18-50 years old with desire of children and needs of embryo transfer.

• Plasma prolactin less than 30.

• Uterine cavity that allow pregnancy, body mass index between 20-30.

• And signed consent inform.

Exclusion Criteria:

• History of estrogen dependent cancer, unknown origin vaginal bleeding.

• Ovarian cyst.

• Contraindications to be pregnant.

• Estrogen allergy.